1
|
Souirti Z, Hmidani M, Lamkadddem A, Khabbach K, Belakhdar S, Charkani D, Mhandez Tlemcani D, Lahmadi N, El Akramine M, Erriouiche S, Berrada A, Ahniba A, Omari M, El Fakir S, Tachfouti N, Rafai MA, Chahid I, Meriam B, Jilla M, Ghaname A, Benmansour Y, Filali Zegzouti Y, Kissani N, Lakhdar A, Belfkih R, Aggouri M, Ouazzani R, Chahidi A, Janati Idrissi A. Prevalence of epilepsy in Morocco: A population-based study. Epilepsia Open 2023; 8:1340-1349. [PMID: 37805672 PMCID: PMC10690708 DOI: 10.1002/epi4.12802] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/13/2023] [Accepted: 07/22/2023] [Indexed: 10/09/2023] Open
Abstract
OBJECTIVE In Morocco, there was a lack of data related to the epidemiology of epilepsy. This data serves as a useful basis for the development of any national intervention or action program against epilepsy in Morocco. Through this study, we aimed to estimate the active and lifetime prevalence of epilepsy in Morocco. METHODS We collected data from eight out of 12 Moroccan regions in two steps: In the screening step, we first used a nationwide telephone diagnosis questionnaire and in the second stage, a team of physicians under the direction of an epileptologist conducted a confirmative survey for suspected cases. We fixed the confidence interval at α = 5% and the precision at 0.02. RESULTS Up to 3184 responded positively to our invitation to participate in this study and were able to answer the questions of the first diagnostic questionnaire. In the diagnostic phase, physicians in neurology reinterviewed all 86 suspected cases using a confirmative diagnosis questionnaire, and 63 persons were confirmed as having lifetime epilepsy and 56 with active epilepsy. The mean age (Mean ± SD) of persons with epilepsy was 35.53 years (±21.36). The prevalence of lifetime and active epilepsy were 19.8 (19.6-20.0) and 17.6 (17.5-17.8) per 1000 (95% confidence interval), respectively. SIGNIFICANCE This is the first study to estimate the active and lifetime prevalence of epilepsy in Morocco according to the international recommendations of the ILAE. The prevalence of lifetime and active epilepsy were 19.8 (15-24.6) and 17.6 (13.3-22.8) per 1000, respectively. We included both children and elderly subjects. The rates of active and lifetime population epilepsy prevalence in Morocco ranged between Asian and sub-Saharan Africa low- and middle-income countries.
Collapse
Affiliation(s)
- Zouhayr Souirti
- Clinical Neurosciences Laboratory, Faculty of Medicine and PharmacySidi Mohamed Ben Abdellah UniversityFezMorocco
- Neurology CenterHassan II University Hospital in FezFezMorocco
| | - Mohammed Hmidani
- Clinical Neurosciences Laboratory, Faculty of Medicine and PharmacySidi Mohamed Ben Abdellah UniversityFezMorocco
| | - Abdelaziz Lamkadddem
- Clinical Neurosciences Laboratory, Faculty of Medicine and PharmacySidi Mohamed Ben Abdellah UniversityFezMorocco
| | - Kawtar Khabbach
- Mohamed VI Hospital Center, Faculty of Medicine and Pharmacy – TangierAbdelmalek Essaadi UniversityTangerMorocco
| | - Salma Belakhdar
- Ibn Rochd University Hospital Center, Faculty of Medicine and PharmacyHassan II University of CasablancaCasablancaMorocco
| | - Doae Charkani
- Outpatient Consultations CenterHassan II University Hospital in FezFezMorocco
| | | | - Nabila Lahmadi
- Neurology CenterHassan II University Hospital in FezFezMorocco
| | | | | | - Asmae Berrada
- Neurology CenterHassan II University Hospital in FezFezMorocco
| | - Asmae Ahniba
- Neurology CenterHassan II University Hospital in FezFezMorocco
| | - Mohammed Omari
- Clinical Research and Community Health Laboratory, Faculty of Medicine and Pharmacy, EpidemiologySidi Mohamed Ben Abdellah UniversityFezMorocco
| | - Samira El Fakir
- Clinical Research and Community Health Laboratory, Faculty of Medicine and Pharmacy, EpidemiologySidi Mohamed Ben Abdellah UniversityFezMorocco
| | - Nabil Tachfouti
- Clinical Research and Community Health Laboratory, Faculty of Medicine and Pharmacy, EpidemiologySidi Mohamed Ben Abdellah UniversityFezMorocco
| | - Mohammed Abdoh Rafai
- Department of Neurology and Clinical Neurophysiological Explorations, Faculty of Medicine and Pharmacy, Ibn Rochd HospitalHassan II University of CasablancaCasablancaMorocco
| | - Imane Chahid
- Department of Pediatric, Faculty of Medicine and Pharmacy, Centre Hospitalier Ibn RochdHassan II University of CasablancaCasablancaMorocco
| | - Bentahar Meriam
- Faculty of Medicine Laayoune, Hôpital Moulay Hassane Ben MehdiIbn Zouhr UniversityLaayouneMorocco
| | - Mariam Jilla
- Provincial Hospital CenterAbdelmalek Essaadi UniversityAl HoceimaMorocco
| | - Aayad Ghaname
- Department of Pediatrics, Faculty of Medicine and Pharmacy, Mohammed VI University HospitalMohammed I University OujdaOujdaMorocco
| | | | | | - Najib Kissani
- Department of Neurology, Marrakech Faculty of Medicine and PharmacyUniversity Hospital Mohamed VIMarrakechMorocco
| | - Abdelhakim Lakhdar
- Department of Neurosurgery, Faculty of Medicine and Pharmacy, Ibn Rochd HospitalHassan II University of CasablancaCasablancaMorocco
| | - Rachid Belfkih
- Mohammed VI Hospital Center, Department of Neurology, Faculty of Medicine and Pharmacy – TangierAbdelmalek Essaadi UniversityTangierMorocco
| | - Mohamed Aggouri
- Mohammed VI Hospital Center, Department of Neurology, Faculty of Medicine and Pharmacy – TangierAbdelmalek Essaadi UniversityTangierMorocco
| | - Reda Ouazzani
- Department of Clinical Neurophysiology, Faculty of Medicine and Pharmacy of Rabat, Avicenne HospitalMohammed V University of RabatRabatMorocco
| | - Abderrahmane Chahidi
- Clinical Neurosciences Laboratory, Faculty of Medicine and PharmacySidi Mohamed Ben Abdellah UniversityFezMorocco
| | - Abdelkrim Janati Idrissi
- Clinical Neurosciences Laboratory, Faculty of Medicine and PharmacySidi Mohamed Ben Abdellah UniversityFezMorocco
| |
Collapse
|
2
|
Temporal trends in the epilepsy treatment gap in low- and low-middle-income countries: A meta-analysis. J Neurol Sci 2022; 434:120174. [DOI: 10.1016/j.jns.2022.120174] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/26/2021] [Revised: 01/01/2022] [Accepted: 01/24/2022] [Indexed: 11/22/2022]
|
3
|
Mohammad QD, Saha NC, Alam MB, Hoque SA, Islam A, Chowdhury RN, Hussain ME, Chowdhury YS, Hossain S, Chowdhury MA, Rahman M, Majumder BK, Salam A, Sarker A, Uddin MK, Moniruzzaman M, Hakim F, Bhuiyan R, Anwar N, Zaman MM. Prevalence of epilepsy in Bangladesh: Results from a national household survey. Epilepsia Open 2020; 5:526-536. [PMID: 33336124 PMCID: PMC7733657 DOI: 10.1002/epi4.12430] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/22/2020] [Revised: 07/03/2020] [Accepted: 08/10/2020] [Indexed: 11/14/2022] Open
Abstract
OBJECTIVE To determine the prevalence and types of epilepsy in Bangladesh. METHODS We conducted a nationwide population-based cross-sectional survey among Bangladeshi population of all ages, except children under one month. We surveyed 9839 participants (urban, 4918; rural, 4920) recruited at their households using multistage cluster sampling. Trained physicians with neurology background confirmed the diagnosis of suspected epilepsy cases identified by interviewer-administered questionnaires. We reported the overall and sex, residence, and age groups-specific prevalence of epilepsy per 1000 populations with 95% confidence interval. RESULTS The national prevalence of epilepsy per 1000 was 8.4 (95% CI 5.6-11.1), urban 8.0 (4.6-11.4), and rural 8.5 (5.60-11.5). The prevalence in adult males and females was 9.2 (5.7-12.6) and 7.7 (3.6-11.7), respectively. The prevalence in children aged <18 years (8.2, 3.4-13.0 was similar to adults (8.5 (5.4-11.4). Among all epilepsy cases, 65.1% had active epilepsy. Their (active epilepsy) prevalence was 5.8 (3.5-8.1). Of them, 63.4% were not receiving treatment. Moreover, those who received allopathy treatment, 72.5% had low adherence leading to a high treatment gap. SIGNIFICANCE Our findings out of this first-ever national survey were similar to other Asian countries. However, the prevalence of active epilepsy and treatment gap were considerably higher. This study serves useful evidence for tailoring interventions aimed to reduce the burden of epilepsy-primarily through targeted community awareness program-and access to antiepileptic treatment in health facilities in Bangladesh.
Collapse
Affiliation(s)
| | - Narayan Chandra Saha
- Department of Pediatric NeurologyNational Institute of Neurosciences and HospitalDhakaBangladesh
| | - Md Badrul Alam
- Department of Clinical NeurologyNational Institute of Neurosciences and HospitalDhakaBangladesh
| | - Seikh Azimul Hoque
- Department of Paediatric NeurologyNational Institute of Neurosciences and HospitalDhakaBangladesh
| | - Ariful Islam
- Department of Paediatric NeurologyNational Institute of Neurosciences and HospitalDhakaBangladesh
| | - Rajib Nayan Chowdhury
- Department of NeurophysiologyNational Institute of Neurosciences and HospitalDhakaBangladesh
| | - Mohammad Enayet Hussain
- Department of NeurophysiologyNational Institute of Neurosciences and HospitalDhakaBangladesh
| | - Yamin Shahriar Chowdhury
- Department of Paediatric NeurologyNational Institute of Neurosciences and HospitalDhakaBangladesh
| | | | - Mahmood Ahmed Chowdhury
- Autism & Child Development CenterChattogram Maa O Shishu Hospital Medical CollegeAgrabad, ChattogramBangladesh
| | | | | | - Abdus Salam
- NeurologyShaheed Sheikh Abu Naser Specialized HospitalKhulnaBangladesh
| | - Amitabh Sarker
- NeurologySher‐E‐Bangla Medical CollegeBarishalBangladesh
| | - Md Kafil Uddin
- National Institute of Neurosciences and HospitalDhakaBangladesh
- NeurologyRajshahi Medical CollegeRajshahiBangladesh
| | - Mohammad Moniruzzaman
- Center for Epidemiologic Research in AsiaShiga University of Medical ScienceOtsuJapan
| | - Ferdous Hakim
- Mental and Neurology Study TeamNational Institute of Neurosciences and HospitalDhakaBangladesh
| | - Rijwan Bhuiyan
- Mental and Neurology Study TeamNational Institute of Neurosciences and HospitalDhakaBangladesh
| | - Nazneen Anwar
- World Health Organization Regional Office for South‐ East AsiaNew DelhiIndia
| | | |
Collapse
|
4
|
Yang K, He Y, Xiao B, Wang J, Feng L. Knowledge, attitudes and practice towards epilepsy among medical staff in Southern China: Does the level of hospitals make a difference? Seizure 2019; 69:221-227. [PMID: 31112828 DOI: 10.1016/j.seizure.2019.05.002] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/02/2019] [Revised: 04/29/2019] [Accepted: 05/03/2019] [Indexed: 01/21/2023] Open
Abstract
PURPOSE To assess knowledge, attitudes, and practice (KAP) toward epilepsy among medical staff from different levels of hospitals in Southern China. METHOD An adapted and structured questionnaire was administered to medical personnel from tertiary (n = 451) and basic-level (n = 448) hospitals in Southern China. The questionnaire comprised of three domains which consisted of 6 items for awareness, 12 items for knowledge and a 14 item scale for attitudes. RESULTS Almost 40% of medical staff in basic-level hospitals held that epilepsy could be caused by evil spirits/eyes, or transmitted from other patients, which was almost 6 times higher than that of tertiary hospitals. The mean score from general knowledge about epilepsy was higher among medical staff in tertiary hospitals than in basic-level hospitals. The mean scores in the general and personal domain of the Chinese Public Attitudes Toward Epilepsy (CPATE) scale were both significantly lower among medical staff in tertiary hospitals, when compared to those of basic-level hospitals. CONCLUSIONS The overall KAP from medical staff in response to seizures, was found to be better in tertiary hospitals than those of basic-level hospitals in Southern China, which was associated with the education level and impact of traditional culture. To date, there is a need for effective public intervention programs in China to improve the awareness of epilepsy and reduce discrimination among medical workers, especially for those working in basic-level hospitals in rural regions, to finally promote a better living environment for patients with epilepsy in China.
Collapse
Affiliation(s)
- Ke Yang
- Department of Neurology, Xiangya Hospital, Central South University, Changsha, Hunan, China
| | - Yue He
- Department of Medical Record and Information, Xiangya Hospital, Central South University, Changsha, Hunan, China
| | - Bo Xiao
- Department of Neurology, Xiangya Hospital, Central South University, Changsha, Hunan, China
| | - Jing Wang
- Department of Neurology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
| | - Li Feng
- Department of Neurology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
| |
Collapse
|
5
|
Vaughan KA, Lopez Ramos C, Buch VP, Mekary RA, Amundson JR, Shah M, Rattani A, Dewan MC, Park KB. An estimation of global volume of surgically treatable epilepsy based on a systematic review and meta-analysis of epilepsy. J Neurosurg 2019; 130:1127-1141. [PMID: 30215556 DOI: 10.3171/2018.3.jns171722] [Citation(s) in RCA: 41] [Impact Index Per Article: 8.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/15/2017] [Accepted: 03/12/2018] [Indexed: 11/06/2022]
Abstract
OBJECTIVE Epilepsy is one of the most common neurological disorders, yet its global surgical burden has yet to be characterized. The authors sought to compile the most current epidemiological data to quantify global prevalence and incidence, and estimate global surgically treatable epilepsy. Understanding regional and global epilepsy trends and potential surgical volume is crucial for future policy efforts and resource allocation. METHODS The authors performed a systematic literature review and meta-analysis to determine the global incidence, lifetime prevalence, and active prevalence of epilepsy; to estimate surgically treatable epilepsy volume; and to evaluate regional trends by WHO regions and World Bank income levels. Data were extracted from all population-based studies with prespecified methodological quality across all countries and demographics, performed between 1990 and 2016 and indexed on PubMed, EMBASE, and Cochrane. The current and annual new case volumes for surgically treatable epilepsy were derived from global epilepsy prevalence and incidence. RESULTS This systematic review yielded 167 articles, across all WHO regions and income levels. Meta-analysis showed a raw global prevalence of lifetime epilepsy of 1099 per 100,000 people, whereas active epilepsy prevalence is slightly lower at 690 per 100,000 people. Global incidence was found to be 62 cases per 100,000 person-years. The meta-analysis predicted 4.6 million new cases of epilepsy annually worldwide, a prevalence of 51.7 million active epilepsy cases, and 82.3 million people with any lifetime epilepsy diagnosis. Differences across WHO regions and country incomes were significant. The authors estimate that currently 10.1 million patients with epilepsy may be surgical treatment candidates, and 1.4 million new surgically treatable epilepsy cases arise annually. The highest prevalences are found in Africa and Latin America, although the highest incidences are reported in the Middle East and Latin America. These regions are primarily low- and middle-income countries; as expected, the highest disease burden falls disproportionately on regions with the fewest healthcare resources. CONCLUSIONS Understanding of the global epilepsy burden has evolved as more regions have been studied. This up-to-date worldwide analysis provides the first estimate of surgical epilepsy volume and an updated comprehensive overview of current epidemiological trends. The disproportionate burden of epilepsy on low- and middle-income countries will require targeted diagnostic and treatment efforts to reduce the global disparities in care and cost. Quantifying global epilepsy provides the first step toward restructuring the allocation of healthcare resources as part of global healthcare system strengthening.
Collapse
Affiliation(s)
- Kerry A Vaughan
- 1Department of Neurosurgery, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania
- 5Global Neurosurgery Initiative/Program in Global Surgery and Social Change, Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts
| | - Christian Lopez Ramos
- 2University of California San Diego School of Medicine, La Jolla, California
- 5Global Neurosurgery Initiative/Program in Global Surgery and Social Change, Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts
| | - Vivek P Buch
- 1Department of Neurosurgery, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania
| | - Rania A Mekary
- 3Department of Pharmaceutical Business and Administrative Sciences, School of Pharmacy, MCPHS University, Boston
- 4Cushing Neurosurgical Outcomes Center, Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School
| | - Julia R Amundson
- 5Global Neurosurgery Initiative/Program in Global Surgery and Social Change, Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts
- 6Miller School of Medicine, University of Miami, Florida
| | - Meghal Shah
- 5Global Neurosurgery Initiative/Program in Global Surgery and Social Change, Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts
- 7Warren Alpert Medical School, Brown University, Providence, Rhode Island
| | - Abbas Rattani
- 5Global Neurosurgery Initiative/Program in Global Surgery and Social Change, Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts
- 8Meharry Medical College, School of Medicine, Nashville; and
| | - Michael C Dewan
- 5Global Neurosurgery Initiative/Program in Global Surgery and Social Change, Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts
- 9Department of Neurosurgery, Vanderbilt University Medical Center, Nashville, Tennessee
| | - Kee B Park
- 5Global Neurosurgery Initiative/Program in Global Surgery and Social Change, Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts
| |
Collapse
|
6
|
Xiao X, Si Y, Mo Q, Liu Y, Li C, Zhao J, Ma S, Si L, Xi Z, Chen L, Wu D, He Q, Hu M, Zhang C, Sun H. Development and validation of the Chinese Version of the Adult Epilepsy Self-Management Scale (C-ESMS) in Western China. Epilepsy Res 2018; 144:43-48. [DOI: 10.1016/j.eplepsyres.2018.04.014] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/13/2018] [Revised: 04/18/2018] [Accepted: 04/29/2018] [Indexed: 01/28/2023]
|
7
|
Boling W, Means M, Fletcher A. Quality of Life and Stigma in Epilepsy, Perspectives from Selected Regions of Asia and Sub-Saharan Africa. Brain Sci 2018; 8:brainsci8040059. [PMID: 29614761 PMCID: PMC5924395 DOI: 10.3390/brainsci8040059] [Citation(s) in RCA: 33] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/13/2017] [Revised: 02/26/2018] [Accepted: 03/29/2018] [Indexed: 11/16/2022] Open
Abstract
Epilepsy is an important and common worldwide public health problem that affects people of all ages. A significant number of individuals with epilepsy will be intractable to medication. These individuals experience an elevated mortality rate and negative psychosocial consequences of recurrent seizures. Surgery of epilepsy is highly effective to stop seizures in well-selected individuals, and seizure freedom is the most desirable result of epilepsy treatment due to the positive improvements in psychosocial function and the elimination of excess mortality associated with intractable epilepsy. Globally, there is inadequate data to fully assess epilepsy-related quality of life and stigma, although the preponderance of information we have points to a significant negative impact on people with epilepsy (PWE) and families of PWE. This review of the psychosocial impact of epilepsy focuses on regions of Asia and Sub-Saharan Africa that have been analyzed with population study approaches to determine the prevalence of epilepsy, treatment gaps, as well as factors impacting psychosocial function of PWE and their families. This review additionally identifies models of care for medically intractable epilepsy that have potential to significantly improve psychosocial function.
Collapse
Affiliation(s)
- Warren Boling
- Department of Neurosurgery, Loma Linda University, Loma Linda, CA 92354, USA.
| | - Margaret Means
- School of Medicine, University of Louisville, Louisville, KY 40202, USA.
| | - Anita Fletcher
- Department of Neurology, University of Louisville, Louisville, KY 40202, USA.
| |
Collapse
|
8
|
Ding X, Zheng Y, Guo Y, Shen C, Wang S, Chen F, Yan S, Ding M. Active epilepsy prevalence, the treatment gap, and treatment gap risk profile in eastern China: A population-based study. Epilepsy Behav 2018; 78:20-24. [PMID: 29161630 DOI: 10.1016/j.yebeh.2017.10.020] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/29/2017] [Revised: 10/14/2017] [Accepted: 10/15/2017] [Indexed: 02/07/2023]
Abstract
We measured the prevalence of active epilepsy and investigated the treatment gap and treatment gap risk profile in eastern China. This was a cross-sectional population-based survey conducted in Zhejiang, China, from October 2013 to March 2014. A total 54,976 people were selected using multi-stage cluster sampling. A two-stage questionnaire-based process was used to identify patients with active epilepsy and to record their demographic, socioeconomic, and epilepsy-related features. Logistic regression analysis was used to analyze risk factors of the treatment gap in eastern China, as adjusted for age and sex. We interviewed 50,035 people; 118 had active epilepsy (2.4‰), among which the treatment gap was 58.5%. In multivariate analysis, failure to receive appropriate antiepileptic treatment was associated with higher seizure frequency of 12-23 times per year (adjusted odds ratio=6.874; 95% confidence interval [CI]=2.372-19.918), >24 times per year (adjusted odds ratio=19.623; 95% CI=4.999-77.024), and a lack of health insurance (adjusted odds ratio=7.284; 95% CI=1.321-40.154). Eastern China has relatively lower prevalence of active epilepsy and smaller treatment gap. Interventions aimed at reducing seizure frequency, improving the health insurance system should be investigated as potential targets to further bridge the treatment gap.
Collapse
Affiliation(s)
- Xiaoyan Ding
- Department of Neurology, Epilepsy Center, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310009, China; Department of Neurology, The Children's Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310052, China
| | - Yang Zheng
- Department of Neurology, Epilepsy Center, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310009, China
| | - Yi Guo
- Department of Neurology, Epilepsy Center, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310009, China
| | - Chunhong Shen
- Department of Neurology, Epilepsy Center, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310009, China
| | - Shan Wang
- Department of Neurology, Epilepsy Center, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310009, China
| | - Feng Chen
- Department of Neurology, Medical Treatment Center Lihuili, Ningbo, Zhejiang 315040, China
| | - Shengqiang Yan
- Department of Neurology, Epilepsy Center, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310009, China
| | - Meiping Ding
- Department of Neurology, Epilepsy Center, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310009, China.
| |
Collapse
|
9
|
Yu P, Zhou D, Liao W, Wang X, Wang Y, Wang T, Wu Y, Lang S, Lin W, Song Y, Zhao H, Cai M, Hong Z. An investigation of the characteristics of outpatients with epilepsy and antiepileptic drug utilization in a multicenter cross-sectional study in China. Epilepsy Behav 2017; 69:126-132. [PMID: 28242476 DOI: 10.1016/j.yebeh.2016.09.021] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/06/2016] [Revised: 09/06/2016] [Accepted: 09/08/2016] [Indexed: 11/20/2022]
Abstract
OBJECTIVES This study aimed to describe the distribution of seizure types, clinical characteristics, and antiepileptic drug (AED) utilization in patients with epilepsy visiting tertiary hospitals in China. METHODS This was an observational, cross-sectional epidemiology study conducted at 11 tertiary hospitals across China from May 2014 to November 2014. A total of 1603 patients, of either sex or any age with confirmed diagnosis of epilepsy, visiting outpatient clinics at tertiary hospitals were screened and enrolled. Demographics, seizure types, frequency, etiologies, comorbidities, and current AED therapy were analyzed using descriptive statistics. RESULTS Overall, the majority (n=1201; 74.9%) of patients were adults (16-59years of age), and the mean (SD) age was 27.5 (15.9) years. A total of 989 (61.7%) patients had partial seizures, and 653 (40.7%) had generalized seizures. The majority experienced monthly (n=663) or yearly (n=625) seizures, with 2.7seizures/month or 2.9seizures/year, respectively. The most commonly reported symptomatic etiologies were traumatic brain injury, encephalitis, and stroke, whereas the most common comorbidities were sleep disorder, headache, anxiety, and depression. Overall, monotherapy was used in 54.1% of patients, while 30.6% of patients used dual therapy. The most commonly prescribed monotherapy for patients with partial seizures was oxcarbazepine (25.9%), while that for patients with generalized seizures was valproic acid (38.9%), and the most common AED combination was valproic acid and lamotrigine. Overall, valproic acid was the most commonly prescribed AED as monotherapy and combination therapy. CONCLUSION Findings from this study provide extensive information on clinical characteristics and utilization of AEDs in Chinese patients with epilepsy which may help physicians make well-informed clinical decisions.
Collapse
Affiliation(s)
- Peimin Yu
- Department of Neurology, Huashan Hospital, Fudan University, Shanghai, China.
| | - Dong Zhou
- West China Hospital of Sichuan University, Chengdu, China.
| | - Weiping Liao
- Neurology, The Second Affiliated Hospital of Guangzhou Medical University, Guangdong, Guangzhou, China.
| | - Xin Wang
- Neurology Department, Zhongshan Hospital Fudan University, Shanghai, China.
| | - Yuping Wang
- Neurology Department, Xuanwu Hospital Capital Medical University, Beijing, China.
| | - Tiancheng Wang
- Neurology, Lanzhou University Second Hospital, Gansu, Lanzhou, China.
| | - Yuan Wu
- First Affiliated Hospital of Guangxi Provincial Medical College, Nanning, China.
| | - Senyang Lang
- Neurology Department, Chinese PLA General Hospital, Beijing, China.
| | - Weihong Lin
- The First Affiliated Hospital of Jilin University, Jilin, Changchun, China.
| | - Yijun Song
- Neurology Department, Tianjin Medical University General Hospital, Tianjin, China.
| | - Heqing Zhao
- Neurology Department, The Second Affiliated Hospital of Soochow University, Jiangsu, Suzhou, China.
| | - Meng Cai
- GlaxoSmithKline (China) Investment Co., Ltd, Shanghai, China.
| | - Zhen Hong
- Department of Neurology, Huashan Hospital, Fudan University, Shanghai, China.
| |
Collapse
|
10
|
Patel V, Xiao S, Chen H, Hanna F, Jotheeswaran AT, Luo D, Parikh R, Sharma E, Usmani S, Yu Y, Druss BG, Saxena S. The magnitude of and health system responses to the mental health treatment gap in adults in India and China. Lancet 2016; 388:3074-3084. [PMID: 27209149 DOI: 10.1016/s0140-6736(16)00160-4] [Citation(s) in RCA: 167] [Impact Index Per Article: 20.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Abstract
This Series paper describes the first systematic effort to review the unmet mental health needs of adults in China and India. The evidence shows that contact coverage for the most common mental and substance use disorders is very low. Effective coverage is even lower, even for severe disorders such as psychotic disorders and epilepsy. There are vast variations across the regions of both countries, with the highest treatment gaps in rural regions because of inequities in the distribution of mental health resources, and variable implementation of mental health policies across states and provinces. Human and financial resources for mental health are grossly inadequate with less than 1% of the national health-care budget allocated to mental health in either country. Although China and India have both shown renewed commitment through national programmes for community-oriented mental health care, progress in achieving coverage is far more substantial in China. Improvement of coverage will need to address both supply-side barriers and demand-side barriers related to stigma and varying explanatory models of mental disorders. Sharing tasks with community-based workers in a collaborative stepped-care framework is an approach that is ripe to be scaled up, in particular through integration within national priority health programmes. India and China need to invest in increasing demand for services through active engagement with the community, to strengthen service user leadership and ensure that the content and delivery of mental health programmes are culturally and contextually appropriate.
Collapse
Affiliation(s)
- Vikram Patel
- London School of Hygiene & Tropical Medicine, London, UK; Centre for the Control of Chronic Conditions, Guragon, India; Centre for Chronic Conditions and Injuries, Public Health Foundation of India, New Delhi, India
| | - Shuiyuan Xiao
- Department of Social Medicine and Health Management, Xiangya School of Public Health, Central South University, China.
| | - Hanhui Chen
- Shanghai Mental Health Center, Shanghai Jiaotong University School of Medicine, Shanghai, China
| | - Fahmy Hanna
- Department of Mental Health and Substance Abuse, World Health Organization, Geneva, Switzerland
| | - A T Jotheeswaran
- Department of Ageing and Life Course, World Health Organization, Geneva, Switzerland
| | - Dan Luo
- Department of Social Medicine and Health Management, Xiangya School of Public Health, Central South University, China
| | - Rachana Parikh
- Centre for Chronic Conditions and Injuries, Public Health Foundation of India, New Delhi, India
| | - Eesha Sharma
- Department of Psychiatry, King George Medical University, Lucknow, Uttar Pradesh, India
| | | | - Yu Yu
- Department of Social Medicine and Health Management, Xiangya School of Public Health, Central South University, China
| | - Benjamin G Druss
- Mental Health School of Public Health: Health Policy & Management, Emory University, Atlanta, GA, USA
| | - Shekhar Saxena
- Department of Mental Health and Substance Abuse, World Health Organization, Geneva, Switzerland
| |
Collapse
|
11
|
Social correlates of mental, neurological, and substance use disorders in China and India: a review. Lancet Psychiatry 2016; 3:882-99. [PMID: 27528098 DOI: 10.1016/s2215-0366(16)30166-3] [Citation(s) in RCA: 33] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/07/2016] [Revised: 06/18/2016] [Accepted: 06/20/2016] [Indexed: 01/10/2023]
Abstract
Understanding the epidemiological profiles of mental, neurological, and substance use disorders provides opportunities for the identification of high-risk population subgroups and for the development of effective country-specific prevention and intervention strategies. Guided by the Conceptual Framework for Action on the Social Determinants of Health by WHO we reviewed the literature to examine the association between a range of social correlates (eg, sex, age, education, income, urbanicity, marital status, and regional differences) and mental, neurological, and substance use disorders in China and India, the most populous countries in the world. We looked for papers on mental, neurological, and substance use disorders with location identifiers and socioeconomic correlates published between 1990 and 2015 and our search found 65 relevant studies from China and 29 from India. Several association patterns between social correlates and mental, neurological, and substance use disorders were not consistent with those reported in high-income countries, including a high concentration of middle-aged men with alcohol use disorders in China and to a lesser extent in India, and a positive association between being married and depression among women in India. Consistent with previous global reports, low education and poverty were associated with higher occurrence of dementia in both China and India, although there is evidence of an interaction between education and income in the risk for dementia in China. Large variations across regions and ethnic groups were consistently documented in China. These unique correlation patterns for mental, neurological, and substance use disorders identified in China and India emphasise the importance of understanding the local social context when planning targeted strategies to reduce the burden of these disorders. High-quality, up-to-date information about the constantly changing pattern of societal factors correlated with mental, neurological, and substance use disorders is urgently needed to help reduce the large and increasing negative social and economic effects that these conditions are having in China, India, and other low-income and middle-income countries.
Collapse
|
12
|
Hawley SR, Ablah E, Hesdorffer D, Pellock JM, Lindeman DP, Paschal AM, Thurman DJ, Liu Y, Warren MB, Schmitz T, Rogers A, St Romain T, Hauser WA. Prevalence of pediatric epilepsy in low-income rural Midwestern counties. Epilepsy Behav 2015; 53:190-6. [PMID: 26588587 DOI: 10.1016/j.yebeh.2015.09.014] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/11/2015] [Accepted: 09/13/2015] [Indexed: 11/15/2022]
Abstract
Epilepsy is one of the most common disabling neurological disorders, but significant gaps exist in our knowledge about childhood epilepsy in rural populations. The present study assessed the prevalence of pediatric epilepsy in nine low-income rural counties in the Midwestern United States overall and by gender, age, etiology, seizure type, and syndrome. Multiple sources of case identification were used, including medical records, schools, community agencies, and family interviews. The prevalence of active epilepsy was 5.0/1000. Prevalence was 5.1/1000 in males and 5.0/1000 in females. Differences by age group and gender were not statistically significant. Future research should focus on methods of increasing study participation in rural communities, particularly those in which research studies are rare.
Collapse
Affiliation(s)
- Suzanne R Hawley
- Wichita State University, Department of Public Health Sciences, 1845 Fairmount Box 43, Wichita, KS 67260-0043, USA
| | - Elizabeth Ablah
- University of Kansas School of Medicine-Wichita, Department of Preventive Medicine and Public Health, 1010 N. Kansas, Wichita, KS 67214, USA
| | - Dale Hesdorffer
- Columbia University, 680 West 168 Street, New York, NY 10032, USA
| | - John M Pellock
- Virginia Commonwealth University, Department of Neurology, P.O. Box 980599, Richmond, VA 23298, USA
| | - David P Lindeman
- University of Kansas Life Span Institute at Parsons, 2601 Gabriel, Parsons, KS 67357, USA
| | - Angelia M Paschal
- The University of Alabama, Department of Health Science, Box 870311, Tuscaloosa, AL 35487-0311, USA
| | - David J Thurman
- Emory University, School of Medicine 201 Dowman Dr. Mailstop 1930-001-1AN, Atlanta, GA 30322, USA
| | - Yi Liu
- Columbia University, 680 West 168 Street, New York, NY 10032, USA
| | - Mary Beth Warren
- University of Kansas Area Health Education Center, 1501 S. Joplin, Pittsburg, KS 66762, USA
| | - Terri Schmitz
- University of Kansas Area Health Education Center, 1501 S. Joplin, Pittsburg, KS 66762, USA
| | - Austin Rogers
- University of Kansas School of Medicine-Wichita, Department of Preventive Medicine and Public Health, 1010 N. Kansas, Wichita, KS 67214, USA
| | | | - W Allen Hauser
- Columbia University, 680 West 168 Street, New York, NY 10032, USA.
| | | |
Collapse
|
13
|
Liu J, Liu Z, Chen T, Xu R. Treatment of epilepsy in China: Formal or informal. Neural Regen Res 2014; 8:3316-24. [PMID: 25206653 PMCID: PMC4145945 DOI: 10.3969/j.issn.1673-5374.2013.35.006] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/01/2013] [Accepted: 09/02/2013] [Indexed: 11/18/2022] Open
Abstract
Antiepileptic drugs are the preferred treatment approach for epileptic patients. However, informal treatment is important for intractable epilepsy. In this study, 500 epileptic patients were recruited from the General Hospital of Beijing Military Area Command of Chinese PLA during the period of October 2009 to January 2012. These involved patients that had been medically treated for at least 1 year. Information on the initial treatment and changes to treatment regimens for each patient was collected through questionnaires. The survey results showed that 52.3% of the epileptic patients searched for treatment after the first seizure, and the mean numbers of seizures was 12.8; 59.8% of the epileptic patients were diagnosed at the first visit, and the mean onset time was 17 months after the first seizure. After diagnosis, patients were treated for an average of 20 days, and the median time was 1 day. Formal anti-epileptic drugs were selected as the first treatment regimen by 67.8% of patients, and 77.5% of these drugs were monotherapies. The mean and median numbers of seizure were respectively 36.9 and 3.0 times before the first regimen was changed. The regimen was changed within the first 6 months by 46.6% of patients, and after the first and second years of treatment, the proportions increased to 54.0% and 71.8%, respectively. In total, 78.5% of the regimens were changed to informal treatments. The informal treatment of epilepsy in China is common, being initiated by either patients or physicians. Enhancing epileptic treatment services in hospital, improving physicians’ professional quality, and strengthening health propaganda may promote the normalization of drug treatment of epilepsy in China.
Collapse
Affiliation(s)
- Jianming Liu
- Bayi Brain Hospital, Affiliated to General Hospital of Beijing Military Area Command of Chinese PLA, Beijing 100700, China
| | - Zhiliang Liu
- Bayi Brain Hospital, Affiliated to General Hospital of Beijing Military Area Command of Chinese PLA, Beijing 100700, China
| | - Tao Chen
- Laser Institute of Engineering, Beijing University of Technology, Beijing 100080, China
| | - Ruxiang Xu
- Bayi Brain Hospital, Affiliated to General Hospital of Beijing Military Area Command of Chinese PLA, Beijing 100700, China
| |
Collapse
|
14
|
Bell GS, Neligan A, Sander JW. An unknown quantity-The worldwide prevalence of epilepsy. Epilepsia 2014; 55:958-62. [DOI: 10.1111/epi.12605] [Citation(s) in RCA: 102] [Impact Index Per Article: 10.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 02/21/2014] [Indexed: 11/29/2022]
Affiliation(s)
- Gail S. Bell
- Department of Clinical and Experimental Epilepsy; NIHR University College London Hospitals Biomedical Research Centre; UCL Institute of Neurology; London United Kingdom
- Epilepsy Society; Chalfont St Peter United Kingdom
| | - Aidan Neligan
- Department of Clinical and Experimental Epilepsy; NIHR University College London Hospitals Biomedical Research Centre; UCL Institute of Neurology; London United Kingdom
| | - Josemir W. Sander
- Department of Clinical and Experimental Epilepsy; NIHR University College London Hospitals Biomedical Research Centre; UCL Institute of Neurology; London United Kingdom
- Epilepsy Society; Chalfont St Peter United Kingdom
- Stichting Epilepsie Instellingen Nederland (SEIN); Heemstede The Netherlands
| |
Collapse
|
15
|
Prevalence of epilepsy in the People's Republic of China: a systematic review. Epilepsy Res 2013; 105:195-205. [PMID: 23507331 DOI: 10.1016/j.eplepsyres.2013.02.002] [Citation(s) in RCA: 46] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/03/2012] [Revised: 12/13/2012] [Accepted: 02/11/2013] [Indexed: 11/22/2022]
Abstract
To date there has not been a nationwide systematic analysis of the prevalence of epilepsy in China. The aim of this study was to estimate the prevalence of epilepsy in mainland China from the published studies and analyze the prevalence of epilepsy by survey method, gender, location, age, seizure type and prevalence of date. We searched the PubMed, Embase, Chinese Biological Medical Literature (CBM), Chinese National Knowledge Infrastructure (CNKI), Chinese Wanfang and Chongqing VIP databases for epidemiological studies on the prevalence of epilepsy. Thirty-eight studies were included that comprised a total sample size of 7,695,961, among whom 13,224 had epilepsy. The overall prevalence of epilepsy was 2.89‰. The prevalence of males and females were 3.83‰ and 3.45‰, respectively. The location-specific prevalence in urban and rural areas was 2.34‰ and 3.17‰, respectively. Prevalence by age groups, 0-9, 10-19, 20-29, 30-39, 40-49, 50-59, 60-69 and ≥70 were 2.21‰, 3.23‰, 3.14‰, 2.83‰, 2.96‰, 2.61‰, 2.76‰ and 2.22‰, respectively. In the subgroup analysis by prevalence date, prevalence rate of epilepsy ranged from 1.19‰ to 6.70‰. As for the seizure types, the overall prevalence of generalized seizures, partial seizures and unclassifiable seizures were 3.12‰, 0.57‰ and 0.23‰, respectively. Overall, the prevalence rate of epilepsy is different for each area in mainland China. A higher prevalence of epilepsy is found in the subgroup analysis by male, rural, age group of 10-19 and generalized seizures. However, more epidemiological studies are needed from other provinces to estimate the overall prevalence of epilepsy in mainland China.
Collapse
|